• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在西弗吉尼亚州实施北达科他州阿片类药物滥用和过量预防计划。

Implementation of a North Dakota opioid misuse and overdose prevention program in West Virginia.

出版信息

J Am Pharm Assoc (2003). 2024 Sep-Oct;64(5):102152. doi: 10.1016/j.japh.2024.102152. Epub 2024 Jul 2.

DOI:10.1016/j.japh.2024.102152
PMID:38964591
Abstract

BACKGROUND

Pharmacy has an important role in combating the opioid epidemic. However, there is a need for more consistency of programs and evidence-based practices across the country.

OBJECTIVES

To describe how an evidence-based opioid misuse and overdose prevention program that originated in North Dakota was implemented in West Virginia and to compare program results between the two states including pharmacist interventions and patient screening for opioid misuse and overdose.

PRACTICE DESCRIPTION

This advancement in practice took place in participating North Dakota and West Virginia community pharmacies.

PRACTICE INNOVATION

An evidence-based program that originated in North Dakota was implemented in West Virginia. The details of this collaboration are outlined in this manuscript.

EVALUATION METHODS

Program screening and pharmacist intervention data were collected using DocStation, an online pharmacy patient management platform.

RESULTS

Thirty-four pharmacies in West Virginia implemented the program. Between April 2022 and September 2023, a total of 34 West Virginia pharmacies conducted 449 documented screenings compared to 12,105 screenings by 81 pharmacies in North Dakota over the same time. There were differences between the states with regard to the proportion of individuals screened as high-risk for opioid use disorder and individuals at risk of accidental opioid overdose likely attributable to different demographics.

CONCLUSION

An opioid misuse and prevention program was successfully implemented in two states, which can serve as a model to implement similar programs in other pharmacies across the United States.

摘要

背景

药学在应对阿片类药物泛滥方面发挥着重要作用。然而,全国各地仍需要更加一致的项目和循证实践。

目的

描述起源于北达科他州的一个基于证据的阿片类药物滥用和过量预防计划如何在西弗吉尼亚州实施,并比较这两个州的计划结果,包括药剂师干预措施和对阿片类药物滥用和过量的患者筛查。

实践描述

这一实践上的进步发生在参与的北达科他州和西弗吉尼亚州社区药房。

实践创新

一个起源于北达科他州的循证项目在西弗吉尼亚州实施。本文档概述了此次合作的细节。

评估方法

使用 DocStation(一种在线药房患者管理平台)收集计划筛查和药剂师干预数据。

结果

西弗吉尼亚州有 34 家药店实施了该计划。在 2022 年 4 月至 2023 年 9 月期间,与北达科他州 81 家药店在同一时期进行的 12,105 次筛查相比,西弗吉尼亚州的 34 家药店共进行了 449 次有记录的筛查。在筛查出高危阿片类药物使用障碍者和可能因不同人口统计学特征而有意外阿片类药物过量风险者的个体比例方面,这两个州存在差异。

结论

在两个州成功实施了一个阿片类药物滥用和预防计划,这可以作为在美国其他药店实施类似计划的模型。

相似文献

1
Implementation of a North Dakota opioid misuse and overdose prevention program in West Virginia.在西弗吉尼亚州实施北达科他州阿片类药物滥用和过量预防计划。
J Am Pharm Assoc (2003). 2024 Sep-Oct;64(5):102152. doi: 10.1016/j.japh.2024.102152. Epub 2024 Jul 2.
2
Implementation of a statewide program within community pharmacies to prevent opioid misuse and accidental overdose.在社区药店实施全州范围内的项目,以防止阿片类药物滥用和意外过量用药。
J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):117-121. doi: 10.1016/j.japh.2019.09.003. Epub 2019 Oct 31.
3
Evaluation of a Program to Screen Patients in Community Pharmacies for Opioid Misuse and Accidental Overdose.评估在社区药店筛查阿片类药物滥用和意外过量用药患者的项目。
Prev Chronic Dis. 2022 Jul 14;19:E41. doi: 10.5888/pcd19.220028.
4
Revisiting the opioid and naloxone education (ONE) program: Program evaluation using the RE-AIM model four years later.重新审视阿片类药物和纳洛酮教育(ONE)计划:四年后使用 RE-AIM 模型进行计划评估。
Res Social Adm Pharm. 2024 Jul;20(7):648-653. doi: 10.1016/j.sapharm.2024.04.005. Epub 2024 Apr 11.
5
Program evaluation of the Opioid and Naloxone Education (ONE Rx) program using the RE-AIM model.使用RE-AIM模型对阿片类药物和纳洛酮教育(ONE Rx)项目进行项目评估。
Res Social Adm Pharm. 2020 Sep;16(9):1248-1254. doi: 10.1016/j.sapharm.2019.11.016. Epub 2019 Nov 30.
6
Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk.将阿片类药物滥用预防措施提前:社区药剂师筛查阿片类药物滥用风险的试点研究。
Res Social Adm Pharm. 2019 Aug;15(8):1032-1036. doi: 10.1016/j.sapharm.2018.07.011. Epub 2018 Jul 17.
7
Patient Experience and Satisfaction with Opioid-Related Screening and Intervention in North Dakota Community Pharmacies.北达科他州社区药房中患者对阿片类药物相关筛查及干预的体验与满意度
J Pharm Pract. 2023 Oct;36(5):1217-1224. doi: 10.1177/08971900221109528. Epub 2022 Jun 15.
8
Opioid risk screening: Program evaluation from the community pharmacists' perspective.阿片类药物风险筛查:社区药剂师视角的项目评估。
J Am Pharm Assoc (2003). 2022 May-Jun;62(3):859-863.e1. doi: 10.1016/j.japh.2021.12.003. Epub 2021 Dec 10.
9
Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose.社区药剂师针对预防阿片类药物滥用和意外过量用药进行定向干预,提高了纳洛酮的患者接受度。
Subst Abus. 2021;42(4):672-677. doi: 10.1080/08897077.2020.1827126. Epub 2020 Oct 12.
10
Patient and pharmacist perspectives on opioid misuse screening and brief interventions in community pharmacies.患者和药剂师对社区药店中阿片类药物滥用筛查和简短干预的看法。
Addict Sci Clin Pract. 2024 Apr 8;19(1):27. doi: 10.1186/s13722-024-00460-y.